A hydrogel-based stem cell delivery system to treat retinal degenerative diseases
Source abstract
Abstract
Regenerative strategies for retinal degenerative diseases are limited by poor cellular survival, distribution and integration after transplantation to the sub-retinal space. To overcome this limitations a stem cell delivery system was developed, taking advantage of the minimally-invasive, injectable and biodegradable properties of a blend of hyaluronan and methylcellulose (HAMC). The physical and biological properties of this unique HAMC formulation were studied. HAMC supported retinal stem-progenitor cell (RSPC) survival and proliferation in vitro. The blend was a viscous solution, exhibiting properties ideal for delivery to the sub-retinal space. In vivo transplantation studies in mice were carried out to investigate both the biodegradability of HAMC in the sub-retinal space over 7 days and the potential of HAMC as a cell delivery vehicle. RSPCs delivered in HAMC were more evenly distributed in the sub-retinal space than those delivered in traditional saline solutions, suggesting that HAMC is a promising vehicle for cellular delivery to the degenerating retina overcoming previously reported barriers to tissue integration in the retina such as cellular aggregation and non-contiguous distribution.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Retinal Development and Disorders · Retinal and Macular Surgery · Corneal Surgery and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Review and update: current treatment trends for patients with retinitis pigmentosa10.1016/j.optm.2008.01.026 ↗
2. Overview of epidemiologic studies of diabetic retinopathy10.1080/09286580701396720 ↗
3. Developments in age-related macular degeneration: diagnosis and treatment
4. Important causes of visual impairment in the world today10.1001/jama.290.15.2057 ↗
5. Ocular neovascularization: an epidemiologic review10.1016/S0039-6257(98)00035-6 ↗
6. Ranibizumab for neovascular age-related macular degeneration10.1056/NEJMoa054481 ↗
7. New paradigms in the treatment of wet AMD: the impact of anti-VEGF therapy10.1038/eye.2009.13 ↗
8. Current and future pharmacological intervention for diabetic retinopathy10.1517/14728214.10.2.441 ↗
9. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD10.1177/112067219900900310 ↗
10. Human fetal RPE transplants in age related macular degeneration (ARMD)
11. Transplantation of neural retina in patients with retinitis pigmentosa
12. Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration10.1111/j.1442-9071.2009.01915.x ↗
13. RPE transplantation and its role in retinal disease10.1016/j.preteyeres.2007.07.001 ↗
14. Neural retinal cell transplantation: ideal versus reality10.1016/S0161-6420(99)90134-3 ↗
15. Stem cells and retinal repair10.1016/j.preteyeres.2004.01.002 ↗
16. Stem cells as tools in regenerative therapy for retinal degeneration10.1001/archophthalmol.2009.65 ↗
17. Stem cell therapy for retinal degeneration: retinal neurons from heterologous sources10.1080/08820530590921882 ↗
18. Retinal stem cells in the adult mammalian eye10.1126/science.287.5460.2032 ↗
19. Facile isolation and the characterization of human retinal stem cells10.1073/pnas.0401596101 ↗
20. Human stem cell ethics: beyond the embryo10.1016/j.stem.2008.05.005 ↗
21. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin10.1038/nn1088 ↗
22. Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior10.1167/iovs.04-0511 ↗
23. Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation10.1016/j.biomaterials.2009.02.046 ↗
24. Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold10.1007/s12177-008-9005-3 ↗
25. A microfabricated scaffold for retinal progenitor cell grafting10.1016/j.biomaterials.2007.10.007 ↗
26. Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space10.1039/b618583e ↗
27. Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells10.1634/stemcells.2005-0111 ↗
28. Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors10.1016/j.biomaterials.2004.08.022 ↗
29. Eye surgery in the elderly10.1016/S1521-6896(03)00006-5 ↗
30. In vitro and in vivo behaviour of biodegradable and injectable PLA/PGA copolymers related to different matrices10.1177/039139880703000412 ↗
31. Collagen gel systems for sustained delivery and tissue engineering10.1016/j.addr.2003.08.004 ↗
32. Novel injectable neutral solutions of chitosan form biodegradable gels in situ10.1016/S0142-9612(00)00116-2 ↗
33. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord10.1016/j.biomaterials.2005.11.015 ↗
34. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair10.1089/ten.tea.2007.0349 ↗
35. An injectable drug delivery platform for sustained combination therapy10.1016/j.jconrel.2009.05.009 ↗
36. Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord10.1016/S0079-6123(06)61027-3 ↗
37. Medical applications of hyaluronan and its derivatives
38. Matrix engineering10.1097/00001721-199102000-00026 ↗
39. Hyaluronate derivatives in drug delivery10.1615/CritRevTherDrugCarrierSyst.v15.i5.30 ↗
40. Hyaluronan and the functional organization of the interphotoreceptor matrix
41. Hyaluronan in the interphotoreceptor matrix of the eye: species differences in content, distribution, ligand binding and degradation10.1006/exer.1997.0422 ↗
42. Loss of retinal progenitor cells leads to an increase in the retinal stem cell population in vivo10.1111/j.1460-9568.2005.04537.x ↗
43. Characteristics of progenitor cells derived from adult ciliary body in mouse, rat, and human eyes10.1167/iovs.06-1034 ↗
44. Observational examination of aggregation and migration during early phase of neurosphere culture of mouse neural stem cells10.1263/jbb.104.231 ↗
45. Visual function and dysfunction in early and late age-related maculopathy10.1016/j.preteyeres.2005.11.002 ↗
46. The use of progenitor cell/biodegradable MMP2-PLGA polymer constructs to enhance cellular integration and retinal repopulation10.1016/j.biomaterials.2009.09.015 ↗
47. Human vitreous hyaluronidase: isolation and characterization10.3109/02713689608995150 ↗
48. Lysosomal hyaluronidase in the subretinal fluid of patients with rhegmatogenous retinal detachments10.1016/0002-9394(82)90191-X ↗
49. Spare the rod and spoil the eye10.1136/bjo.2004.062547 ↗
50. Mouse models of age-related macular degeneration10.1016/j.exer.2005.10.012 ↗
51. Molecular pathology of age-related macular degeneration10.1016/j.preteyeres.2008.10.001 ↗